 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval% F/ S, Q: ], F. a
2 a; _* e: K7 O# K, q; k
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
- s2 P0 Z2 d: A) R S) E
; b2 @# u5 ?; l: B: cBY THE EDMONTON JOURNAL FEBRUARY 16, 2007& f% c; }, U6 j, |! X+ T; U$ L3 o
. ^. x4 Q2 _2 v& i* ]
5 h( [7 D8 I, A& E1 n3 S3 b$ kEDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
* W5 g7 a" V. C7 n* S/ V) l$ G3 X* P, [7 O' O6 h9 ]4 G
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."9 J* ^& s$ D, E
' E) O; R4 z! W: ]9 y# p, I" ~5 G
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
2 g1 B# y# p3 D7 k7 s/ p. F+ p, D5 d6 j% s
It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.8 k1 b: d) w3 U, @3 m
6 H' M1 N M4 N5 H8 B' y+ g. @* O' q
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
; m( \& w; c9 `% M4 e* i" }+ X" |5 p. y
"As a scientist, it's one of the highlights of my CAREER," Shan said.2 j1 _4 Q. L4 Y5 b$ Z/ K$ z
* q& Q9 m1 x9 }3 Q5 H
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
* m( @! h9 g% ?& u" J& s, U9 {9 H- M7 G. k
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.4 p0 }) l0 ?, s% b1 f
3 ~# m- S6 c' h2 i2 w8 {; TGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
. h, D0 ? G& j; D3 p( \5 P C+ v$ u( F* r0 _* [& L" P; Q
The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.# E* X$ Z3 p5 o- M+ h( q5 f$ A# p
A5 c. G9 |& P/ G" J
0 G8 P- C, W% T( g j
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
( ?8 `. X* o/ } W9 h. r1 e( w% y6 K
发表于 2015-2-28 19:45
